Metropolitan Life Insurance Company (MetLife)’s Glaukos GKOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,493
| Closed | -$235K | – | 858 |
|
|
2024
Q1 | $235K | Sell |
2,493
-207
| -8% | -$18.5K | 0.01% | 655 |
|
|
2023
Q4 | $215K | Hold |
2,700
| – | – | 0.01% | 700 |
|
|
2023
Q3 | $203K | Buy |
2,700
+139
| +5% | +$10.4K | 0.01% | 668 |
|
|
2023
Q2 | $182K | Buy |
2,561
+97
| +4% | +$5.57K | 0.01% | 715 |
|
|
2023
Q1 | $123K | Sell |
2,464
-364
| -13% | -$17.7K | 0.01% | 901 |
|
|
2022
Q4 | $124K | Buy |
2,828
+101
| +4% | +$4.98K | 0.01% | 946 |
|
|
2022
Q3 | $145K | Sell |
2,727
-202
| -7% | -$10.4K | 0.01% | 812 |
|
|
2022
Q2 | $133K | Hold |
2,929
| – | – | 0.01% | 902 |
|
|
2022
Q1 | $169K | Sell |
2,929
-8,866
| -75% | -$469K | 0.01% | 901 |
|
|
2021
Q4 | $524K | Hold |
11,795
| – | – | 0.01% | 1388 |
|
|
2021
Q3 | $568K | Sell |
11,795
-848
| -7% | -$47K | 0.01% | 1373 |
|
|
2021
Q2 | $1.07M | Buy |
12,643
+778
| +7% | +$63.9K | 0.02% | 959 |
|
|
2021
Q1 | $996K | Sell |
11,865
-451
| -4% | -$39.7K | 0.01% | 933 |
|
|
2020
Q4 | $927K | Sell |
12,316
-249
| -2% | -$15.7K | 0.01% | 926 |
|
|
2020
Q3 | $622K | Hold |
12,565
| – | – | 0.01% | 1061 |
|
|
2020
Q2 | $483K | Sell |
12,565
-3
| -0% | -$112 | 0.01% | 1227 |
|
|
2020
Q1 | $388K | Buy |
12,568
+317
| +3% | +$16.3K | 0.01% | 1202 |
|
|
2019
Q4 | $667K | Buy |
12,251
+660
| +6% | +$40.2K | 0.01% | 1151 |
|
|
2019
Q3 | $725K | Buy |
11,591
+544
| +5% | +$38.3K | 0.01% | 1053 |
|
|
2019
Q2 | $833K | Buy |
11,047
+230
| +2% | +$16.5K | 0.01% | 1007 |
|
|
2019
Q1 | $848K | Sell |
10,817
-220
| -2% | -$14.7K | 0.02% | 972 |
|
|
2018
Q4 | $620K | Buy |
11,037
+129
| +1% | +$7.76K | 0.01% | 1077 |
|
|
2018
Q3 | $708K | Hold |
10,908
| – | – | 0.01% | 1130 |
|
|
2018
Q2 | $443K | Buy |
10,908
+1,171
| +12% | +$41.7K | 0.01% | 1404 |
|
|
2018
Q1 | $300K | Hold |
9,737
| – | – | ﹤0.01% | 1618 |
|
|
2017
Q4 | $250K | Sell |
9,737
-9,995
| -51% | -$297K | ﹤0.01% | 1765 |
|
|
2017
Q3 | $651K | Hold |
19,732
| – | – | ﹤0.01% | 1511 |
|
|
2017
Q2 | $818K | Buy |
19,732
+7,562
| +62% | +$326K | 0.01% | 1362 |
|
|
2017
Q1 | $624K | Sell |
12,170
-634
| -5% | -$27.6K | ﹤0.01% | 1506 |
|
|
2016
Q4 | $439K | Hold |
12,804
| – | – | ﹤0.01% | 1824 |
|
|
2016
Q3 | $483K | Hold |
12,804
| – | – | ﹤0.01% | 1727 |
|
|
2016
Q2 | $373K | Buy |
+12,804
| New | +$296K | ﹤0.01% | 1877 |
|
Other funds holding GKOS
BCM
FAM
Metropolitan Life Insurance Company (MetLife)'s GKOS Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Glaukos (GKOS) in Q2 2024, closing a stake of 2,493 shares — an estimated $235K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in GKOS in Q2 2016 and held it in 32 quarters. The position peaked at $1.07M in Q2 2021. 282 funds tracked by Wall St. Rank hold GKOS as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Glaukos position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,493 Glaukos shares in Q2 2024, an estimated $235K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Glaukos in Q2 2016 and held it in 32 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Glaukos position peaked at $1.07M in Q2 2021.
- 282 funds tracked by Wall St. Rank held Glaukos as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.